Application

QVOKLY

Ascendis Pharma Endocrinology Division A/S

Trademark/Service Mark Application, Principal Register

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

Serial Number: 90008232
Filing Date: 06/18/020

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 90008232
MARK INFORMATION
*MARK QVOKLY
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT QVOKLY
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Ascendis Pharma Endocrinology Division A/S
*MAILING ADDRESS Tuborg Boulevard 5
*CITY Hellerup
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY Denmark
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
2900
*EMAIL ADDRESS XXXX
LEGAL ENTITY INFORMATION
TYPE aktieselskab (a/s)
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY WHERE LEGALLY ORGANIZED Denmark
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 005 
*IDENTIFICATION Pharmaceutical preparations for the treatment of growth disorders, pharmaceutical preparations for the treatment of endocrine disorders, pharmaceutical preparations for the treatment of bone disorders, pharmaceutical preparations for the treatment of cancer, pharmaceutical preparations for the treatment of infectious diseases; diagnostic preparations for medical use, namely, diagnostic preparations for identifying and detecting growth hormone deficiency, endocrine disorders, bone disorders, cancer, and infectious diseases
FILING BASIS SECTION 1(b)
FILING BASIS SECTION 44(d)
       FOREIGN APPLICATION NUMBER VR 2020 00773
       FOREIGN APPLICATION
       COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
Denmark
       FOREIGN FILING DATE 12/30/2019
       INTENT TO
       PERFECT 44(d)
At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
INTERNATIONAL CLASS 009 
*IDENTIFICATION Computer software and computer programs for use in providing medical advice and advice on medications for treatment, patient assistance and health insurance in the field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely a downloadable software application for sharing information related to growth disorders, endocrine disorders, bone disorders, cancer, infectious diseases and the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases for use by patients with growth hormone disorders, hypoparathyroidism, skeletal dysplasia, and diabetes in the medical field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; computer application software for mobile phones, tablet computers handheld computers and personal computers, namely, software that coordinates the delivery of health care services between health care providers, patients and those parties responsible for the payment of health care services, namely software that allows individuals seeking medical education, information and services to locate a physician and treatment facility in their geographic area for medical treatment and allows physicians and health care professionals to communicate their credentials and specialization to patients and parties responsible for payment of healthcare services; computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, software that enables health care providers to monitor patients, communicate clinical information relevant to a patient's care, provide and exchange information concerning patients and the health care services provided to patients; downloadable software, software applications and mobile applications for providing co-pay and other financial or medical access support; downloadable computer software for providing a communications platform enabling users to share health and healthcare information; downloadable software, software applications and mobile applications for the measurement of height, weight, blood pressure, serum calcium, blood glucose, and heart rate; downloadable software, software applications and mobile applications for providing, exchanging, retrieving and analyzing health and healthcare information; software for medical purposes, namely, for formatting, viewing and transmitting medical data collected and stored on hormone injection pens and pumps between injection pens and pumps and portable electronic devices; computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely a downloadable software application for providing healthcare-related information, medication reminders, and tracking medication dosing history; the foregoing related to pharmaceutical preparations for the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases
FILING BASIS SECTION 1(b)
FILING BASIS SECTION 44(d)
       FOREIGN APPLICATION NUMBER VR 2020 00773
       FOREIGN APPLICATION
       COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
Denmark
       FOREIGN FILING DATE 12/30/2019
       INTENT TO
       PERFECT 44(d)
At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
INTERNATIONAL CLASS 010 
*IDENTIFICATION Medical devices for injection, dosage and control of pharmaceuticals, namely medical devices for injection, dosage and control of pharmaceuticals for the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; syringes for medical purposes and for injections; syringes for injection for medical and surgical use, namely syringes in the form of pens for surgical use; digitally connected medical devices for monitoring the dosage of pharmaceutical preparations for use in connection with management of growth hormone disorders, hypoparathyroidism, skeletal dysplasia, cancer and diabetes; medical apparatus, namely, infusion and injection devices for administering drugs; medical apparatus and instruments for diagnostic purposes for use in dosage management for medicines containing software for medical information management for use in web-based physical and psychological examination and assessment of patients remotely and in a clinic; medical apparatus for use in dosage management of medicines, incorporating software for medical information management for guidance and control of medicines and for therapeutic use in web-based physical and psychological examination and assessment of patients remotely and at a clinic
FILING BASIS SECTION 1(b)
FILING BASIS SECTION 44(d)
       FOREIGN APPLICATION NUMBER VR 2020 00773
       FOREIGN APPLICATION
       COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
Denmark
       FOREIGN FILING DATE 12/30/2019
       INTENT TO
       PERFECT 44(d)
At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
ATTORNEY INFORMATION
NAME Shannon Marie McKeon
ATTORNEY DOCKET NUMBER 067328.tbd
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME Dykema Gossett PLLC
STREET 1301 K Str., N.W., Suite 1100
CITY Washington
STATE District of Columbia
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 20005
PHONE 202-906-8600
EMAIL ADDRESS tm@dykema.com
OTHER APPOINTED ATTORNEY Eric T. Fingerhut
CORRESPONDENCE INFORMATION
NAME Shannon Marie McKeon
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE tm@dykema.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) smckeon@dykema.com; efingerhut@dykema.com; jpisigan@dykema.com
FEE INFORMATION
APPLICATION FILING OPTION TEAS Standard
NUMBER OF CLASSES 3
APPLICATION FOR REGISTRATION PER CLASS 275
*TOTAL FEES DUE 825
*TOTAL FEES PAID 825
SIGNATURE INFORMATION
SIGNATURE /Shannon Marie McKeon/
SIGNATORY'S NAME Shannon Marie McKeon
SIGNATORY'S POSITION Authorized U.S. Attorney, VA bar member
SIGNATORY'S PHONE NUMBER 202-906-8600
DATE SIGNED 06/18/2020



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)


Trademark/Service Mark Application, Principal Register

Serial Number: 90008232
Filing Date: 06/18/020

To the Commissioner for Trademarks:

MARK: QVOKLY (Standard Characters, see mark)
The literal element of the mark consists of QVOKLY. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Ascendis Pharma Endocrinology Division A/S, a aktieselskab (a/s) legally organized under the laws of Denmark, having an address of
      Tuborg Boulevard 5
      Hellerup 2900
      Denmark
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 005:  Pharmaceutical preparations for the treatment of growth disorders, pharmaceutical preparations for the treatment of endocrine disorders, pharmaceutical preparations for the treatment of bone disorders, pharmaceutical preparations for the treatment of cancer, pharmaceutical preparations for the treatment of infectious diseases; diagnostic preparations for medical use, namely, diagnostic preparations for identifying and detecting growth hormone deficiency, endocrine disorders, bone disorders, cancer, and infectious diseases
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of priority based on Denmark application number VR 2020 00773, filed 12/30/2019.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.


International Class 009:  Computer software and computer programs for use in providing medical advice and advice on medications for treatment, patient assistance and health insurance in the field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely a downloadable software application for sharing information related to growth disorders, endocrine disorders, bone disorders, cancer, infectious diseases and the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases for use by patients with growth hormone disorders, hypoparathyroidism, skeletal dysplasia, and diabetes in the medical field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; computer application software for mobile phones, tablet computers handheld computers and personal computers, namely, software that coordinates the delivery of health care services between health care providers, patients and those parties responsible for the payment of health care services, namely software that allows individuals seeking medical education, information and services to locate a physician and treatment facility in their geographic area for medical treatment and allows physicians and health care professionals to communicate their credentials and specialization to patients and parties responsible for payment of healthcare services; computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, software that enables health care providers to monitor patients, communicate clinical information relevant to a patient's care, provide and exchange information concerning patients and the health care services provided to patients; downloadable software, software applications and mobile applications for providing co-pay and other financial or medical access support; downloadable computer software for providing a communications platform enabling users to share health and healthcare information; downloadable software, software applications and mobile applications for the measurement of height, weight, blood pressure, serum calcium, blood glucose, and heart rate; downloadable software, software applications and mobile applications for providing, exchanging, retrieving and analyzing health and healthcare information; software for medical purposes, namely, for formatting, viewing and transmitting medical data collected and stored on hormone injection pens and pumps between injection pens and pumps and portable electronic devices; computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely a downloadable software application for providing healthcare-related information, medication reminders, and tracking medication dosing history; the foregoing related to pharmaceutical preparations for the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of priority based on Denmark application number VR 2020 00773, filed 12/30/2019.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.


International Class 010:  Medical devices for injection, dosage and control of pharmaceuticals, namely medical devices for injection, dosage and control of pharmaceuticals for the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; syringes for medical purposes and for injections; syringes for injection for medical and surgical use, namely syringes in the form of pens for surgical use; digitally connected medical devices for monitoring the dosage of pharmaceutical preparations for use in connection with management of growth hormone disorders, hypoparathyroidism, skeletal dysplasia, cancer and diabetes; medical apparatus, namely, infusion and injection devices for administering drugs; medical apparatus and instruments for diagnostic purposes for use in dosage management for medicines containing software for medical information management for use in web-based physical and psychological examination and assessment of patients remotely and in a clinic; medical apparatus for use in dosage management of medicines, incorporating software for medical information management for guidance and control of medicines and for therapeutic use in web-based physical and psychological examination and assessment of patients remotely and at a clinic
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of priority based on Denmark application number VR 2020 00773, filed 12/30/2019.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.




The owner's/holder's proposed attorney information: Shannon Marie McKeon. Other appointed attorneys are Eric T. Fingerhut. Shannon Marie McKeon of Dykema Gossett PLLC, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      1301 K Str., N.W., Suite 1100
      Washington, District of Columbia 20005
      United States
      202-906-8600(phone)
      tm@dykema.com
The docket/reference number is 067328.tbd.
Shannon Marie McKeon submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.
The applicant's current Correspondence Information:
      Shannon Marie McKeon
       PRIMARY EMAIL FOR CORRESPONDENCE: tm@dykema.com
       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): smckeon@dykema.com; efingerhut@dykema.com; jpisigan@dykema.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $825 has been submitted with the application, representing payment for 3 class(es).

Declaration

Declaration Signature

Signature: /Shannon Marie McKeon/   Date: 06/18/2020
Signatory's Name: Shannon Marie McKeon
Signatory's Position: Authorized U.S. Attorney, VA bar member
Payment Sale Number: 90008232
Payment Accounting Date: 06/18/2020

Serial Number: 90008232
Internet Transmission Date: Thu Jun 18 10:55:49 ET 2020
TEAS Stamp: USPTO/BAS-XX.XXX.XXX.XXX-202006181055498
41882-90008232-7103fa44d746cd7f591d24eda
3ede98dde8ef5b5a7386c138c83856c7781349ae
2-DA-55490418-20200618104315919077

Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed